Jie Chengying Xiu

Overview

Jie Chengying Xiu’s practice specializes in corporate and securities laws, mergers and acquisitions, and a wide range of business and commercial matters. She represents high-profile, complex M&A and securities offering projects across multiple regions, including East and Southeast Asia, Europe, and North America. Jie serves corporations and individuals in transactions ranging from billion-dollar M&A deals to startup financings.

Her expertise includes advising clients on public offerings, including IPOs, SPAC IPOs and reverse mergers, and compliance with federal and state securities laws. Jie has a substantial track record in helping companies navigate listings on major exchanges such as NASDAQ, NYSE, and OTC Markets, as well as representing them in both public and private offerings of debt and equity securities.

Her client base spans industries including investment banking, financial services, high-tech, pharmaceuticals and biotech, manufacturing, consumer products, real estate, retail and fashion, education, advertising, and maritime sectors. Before joining her current firm, Jie was counsel at a prominent international law firm.

EXPERIENCE

Led a $300 million sale of a food logistics company to a Nasdaq-listed SPAC and continued to represent the public company post-listing.
Advised major shareholders in the $119.5 million IPO of a radiotherapy and diagnostic imaging equipment manufacturer.
Advised a multinational Canadian company in issuing over $1 billion in notes and term loans.
Advised a US private equity fund in its $150 million private placement.
Advised one of the largest U.S. state pension funds in its $100 million investment in an Asian private equity fund.
Advised China’s largest railcar manufacturer in a successful $560 million subway vehicle supply contract for the city of Boston and the establishment of its first North American factory.
Advised a Chinese real estate conglomerate in a partnership with a major Hollywood movie studio to develop a theme park in China.
Represented leading Chinese real estate developers in U.S. real estate investments and development projects.
Advised an Indian conglomerate in the acquisition of Digital Domain, a renowned visual effects studio.
Advised cross-border M&A transactions between major pharmaceutical and biotech companies in the U.S. and China.
Represented numerous companies in their IPOs, reverse mergers, and PIPE offerings in the U.S.
Provided counsel on the Securities Exchange Act compliance, including filing Forms 10-Ks, 10-Qs, 8-Ks, proxies, and organizing annual shareholder meetings.
Ongoing representation of U.S. public companies regarding corporate governance and compliance with SEC, NYSE and NASDAQ rules and regulations.
Collaborated with litigation teams on white-collar criminal cases, large-scale securities class actions, and the development of litigation prevention and risk management strategies for corporate clients, individuals, and securities transactions.

RECOGNITION

Recognized as a New York “Rising Star” from 2011 to 2016 in the Corporate and Business section by Super Lawyers Magazine.
Named one of the “Top Women Attorneys in the New York Metro Area” in the M&A section by Super Lawyers Magazine (2012-2016).
Recipient of the Outstanding Contribution to AFS Board Award.
Awarded the Outstanding 50 Asian Americans in Business Award in 2014, a prestigious recognition of Asian American leaders.
Featured as the first female partner in the firm’s March 2021 Becker Bulletin, in honor of Women’s History Month.
Interviewed by Law.com in 2020 as part of its prestigious “How I Made Partner” series.